Reminyl®
Reminly® (galantamine) is the latest reversible cholinesterase inhibitor (2001), introduced by Janssen Pharmaceuticals in this category.
The drug is a natural alkaloid originating from the bulbs of the common snowdrop flower; also know as the daffodil or Galanthus nivalis.
It works both by inhibiting the enzyme that breaks down acetylcholine and by stimulating certain receptors in the brain to release more acetylcholine.
Compared to Aricept® and similar to Exelon®, Reminyl® requires multiple daily dosages and a slow dosage titration to limit GI side effects.
Hepatotoxicity, however, has not been noted with Reminyl® as it has for Cognex®. Overall, Reminyl® appears to be a viable first-line treatment option for Alzheimer\'s disease.
The drug improves cognitive functioning as assessed by the ADAS-cog/11 and the CIBIC-plus scales.
However, there are no head-to-head studies that compare Reminyl® with other cholinesterase inhibitors.
In other countries, where the drug is know as Novalin®, Reminyl® has been used off-label for other conditions, including glaucoma, muscular dystrophy, myasthenia gravis, and neuritis.
Reminly® (galantamine) is the latest reversible cholinesterase inhibitor (2001), introduced by Janssen Pharmaceuticals in this category.
The drug is a natural alkaloid originating from the bulbs of the common snowdrop flower; also know as the daffodil or Galanthus nivalis.
It works both by inhibiting the enzyme that breaks down acetylcholine and by stimulating certain receptors in the brain to release more acetylcholine.
Compared to Aricept® and similar to Exelon®, Reminyl® requires multiple daily dosages and a slow dosage titration to limit GI side effects.
Hepatotoxicity, however, has not been noted with Reminyl® as it has for Cognex®. Overall, Reminyl® appears to be a viable first-line treatment option for Alzheimer\'s disease.
The drug improves cognitive functioning as assessed by the ADAS-cog/11 and the CIBIC-plus scales.
However, there are no head-to-head studies that compare Reminyl® with other cholinesterase inhibitors.
In other countries, where the drug is know as Novalin®, Reminyl® has been used off-label for other conditions, including glaucoma, muscular dystrophy, myasthenia gravis, and neuritis.